Home
>
National Drug Code (NDC)
>
Mirtazapine
Mirtazapine - 0093-7303-65 - (Mirtazapine)
Drug Information of Mirtazapine
| Product NDC: | 0093-7303 |
| Proprietary Name: | Mirtazapine |
| Non Proprietary Name: | Mirtazapine |
| Active Ingredient(s): | 15 mg/1 & nbsp; Mirtazapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mirtazapine
| Product NDC: | 0093-7303 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076901 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050901 |
Package Information of Mirtazapine
| Package NDC: | 0093-7303-65 |
| Package Description: | 5 BLISTER PACK in 1 BOX (0093-7303-65) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-7303-18) |
NDC Information of Mirtazapine
| NDC Code | 0093-7303-65 |
| Proprietary Name | Mirtazapine |
| Package Description | 5 BLISTER PACK in 1 BOX (0093-7303-65) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-7303-18) |
| Product NDC | 0093-7303 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mirtazapine |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20050901 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | MIRTAZAPINE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
